<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34670874</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2005-1212</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Gut and liver</Title>
          <ISOAbbreviation>Gut Liver</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Type 2 Autoimmune Pancreatitis: Consensus and Controversies.</ArticleTitle>
        <Pagination>
          <StartPage>357</StartPage>
          <EndPage>365</EndPage>
          <MedlinePgn>357-365</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.5009/gnl210241</ELocationID>
        <Abstract>
          <AbstractText>Autoimmune pancreatitis (AIP) has attracted much attention in the last two decades, and due to the diagnostic value of immunoglobulin G4 (IgG4), the number of cases diagnosed in clinical practice has markedly increased. However, in contrast to prototypic IgG4-related type 1 AIP, a minor subtype of AIP, referred to as type 2 AIP, is less widely known and has thus not yet been characterized in detail. Type 2 AIP is unrelated to IgG4 and is a completely distinct entity from type 1 AIP. One confusing factor is that the two types of AIP share patterns of clinical presentation (e.g., acute pancreatitis and painless jaundice) and imaging abnormalities (e.g., diffuse or segmental enlargement). Since there are currently no established serum markers, the diagnosis of type 2 AIP is highly challenging and requires the tissue confirmation of neutrophilic injury to the pancreatic ducts, a finding designated as a granulocytic epithelial lesion. Approximately one-third of cases are associated with inflammatory bowel disease, particularly ulcerative colitis; however, the pathological relationship between these two conditions has not yet been clarified. Unanswered questions relate to its pathophysiology, the potential development of a similar granulocytic injury in other organs, and the characteristics of pediatric cases. This review summarizes consensus and controversies surrounding type 2 AIP, with the aim of increasing awareness and highlighting the unmet needs of this underrecognized condition.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zen</LastName>
            <ForeName>Yoh</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0001-8370-6508</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Liver Studies, King's College Hospital &amp; King's College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Gut Liver</MedlineTA>
        <NlmUniqueID>101316452</NlmUniqueID>
        <ISSNLinking>1976-2283</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000081012" MajorTopicYN="Y">Autoimmune Pancreatitis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010195" MajorTopicYN="Y">Pancreatitis</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Autoimmune pancreatitis</Keyword>
        <Keyword MajorTopicYN="N">Colitis</Keyword>
        <Keyword MajorTopicYN="N">Granulocytic epithelial lesion</Keyword>
        <Keyword MajorTopicYN="N">Idiopathic duct-centric pancreatitis</Keyword>
        <Keyword MajorTopicYN="N">Immunoglobulin G</Keyword>
        <Keyword MajorTopicYN="N">ulcerative</Keyword>
      </KeywordList>
      <CoiStatement>
<b>CONFLICTS OF INTEREST</b>
. No potential conflict of interest relevant to this article was reported.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>21</Day>
          <Hour>5</Hour>
          <Minute>44</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34670874</ArticleId>
        <ArticleId IdType="pmc">PMC9099380</ArticleId>
        <ArticleId IdType="doi">10.5009/gnl210241</ArticleId>
        <ArticleId IdType="pii">gnl210241</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119–1127. doi: 10.1097/00000478-200308000-00009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000478-200308000-00009</ArticleId>
            <ArticleId IdType="pubmed">12883244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zamboni G, Lüttges J, Capelli P, et al.  Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552–563. doi: 10.1007/s00428-004-1140-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00428-004-1140-z</ArticleId>
            <ArticleId IdType="pubmed">15517359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chari ST, Kloeppel G, Zhang L, et al.  Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;39:549–554. doi: 10.1097/MPA.0b013e3181e4d9e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPA.0b013e3181e4d9e5</ArticleId>
            <ArticleId IdType="pubmed">20562576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart PA, Kamisawa T, Brugge WR, et al.  Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771–1776. doi: 10.1136/gutjnl-2012-303617.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2012-303617</ArticleId>
            <ArticleId IdType="pmc">PMC3862979</ArticleId>
            <ArticleId IdType="pubmed">23232048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart PA, Zen Y, Chari ST. Recent advances in autoimmune pancreatitis. Gastroenterology. 2015;149:39–51. doi: 10.1053/j.gastro.2015.03.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2015.03.010</ArticleId>
            <ArticleId IdType="pubmed">25770706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart PA, Levy MJ, Smyrk TC, et al.  Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience. Gut. 2016;65:1702–1709. doi: 10.1136/gutjnl-2015-309275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2015-309275</ArticleId>
            <ArticleId IdType="pubmed">26085439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oh D, Song TJ, Moon SH, et al.  Type 2 autoimmune pancreatitis (idiopathic duct-centric pancreatitis) highlighting patients presenting as clinical acute pancreatitis: a single-center experience. Gut Liver. 2019;13:461–470. doi: 10.5009/gnl18429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5009/gnl18429</ArticleId>
            <ArticleId IdType="pmc">PMC6622566</ArticleId>
            <ArticleId IdType="pubmed">30970429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghazale A, Chari ST, Smyrk TC, et al.  Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646–1653. doi: 10.1111/j.1572-0241.2007.01264.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1572-0241.2007.01264.x</ArticleId>
            <ArticleId IdType="pubmed">17555461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoue D, Yoshida K, Yoneda N, et al.  IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 2015;94:e680.  doi: 10.1097/MD.0000000000000680.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000000680</ArticleId>
            <ArticleId IdType="pmc">PMC4602507</ArticleId>
            <ArticleId IdType="pubmed">25881845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zen Y, Grammatikopoulos T, Hadzic N. Autoimmune pancreatitis in children: insights into the diagnostic challenge. J Pediatr Gastroenterol Nutr. 2014;59:e42–e45. doi: 10.1097/MPG.0b013e3182994559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPG.0b013e3182994559</ArticleId>
            <ArticleId IdType="pubmed">25347159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460–1471. doi: 10.1016/S0140-6736(14)60720-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(14)60720-0</ArticleId>
            <ArticleId IdType="pubmed">25481618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamisawa T, Zen Y, Nakazawa T, Okazaki K. Advances in IgG4-related pancreatobiliary diseases. Lancet Gastroenterol Hepatol. 2018;3:575–585. doi: 10.1016/S2468-1253(18)30121-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2468-1253(18)30121-3</ArticleId>
            <ArticleId IdType="pubmed">30047448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Pretis N, Frulloni L. Autoimmune pancreatitis type 2. Curr Opin Gastroenterol. 2020;36:417–420. doi: 10.1097/MOG.0000000000000655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MOG.0000000000000655</ArticleId>
            <ArticleId IdType="pubmed">32618613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lorenzo D, Maire F, Stefanescu C, et al.  Features of autoimmune pancreatitis associated with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018;16:59–67. doi: 10.1016/j.cgh.2017.07.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cgh.2017.07.033</ArticleId>
            <ArticleId IdType="pubmed">28782667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimosegawa T, Chari ST, Frulloni L, et al.  International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–358. doi: 10.1097/MPA.0b013e3182142fd2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPA.0b013e3182142fd2</ArticleId>
            <ArticleId IdType="pubmed">21412117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanno A, Masamune A, Okazaki K, et al.  Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015;44:535–539. doi: 10.1097/MPA.0000000000000325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPA.0000000000000325</ArticleId>
            <ArticleId IdType="pubmed">25815647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zen Y, Deshpande V. Tumefactive inflammatory diseases of the pancreas. Am J Pathol. 2019;189:82–93. doi: 10.1016/j.ajpath.2018.05.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2018.05.022</ArticleId>
            <ArticleId IdType="pubmed">30558726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Chari S, Smyrk TC, et al.  Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas. 2011;40:1172–1179. doi: 10.1097/MPA.0b013e318233bec5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPA.0b013e318233bec5</ArticleId>
            <ArticleId IdType="pubmed">21975436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khandelwal A, Inoue D, Takahashi N. Autoimmune pancreatitis: an update. Abdom Radiol (NY) 2020;45:1359–1370. doi: 10.1007/s00261-019-02275-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00261-019-02275-x</ArticleId>
            <ArticleId IdType="pubmed">31650376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23–28. doi: 10.1038/modpathol.3800689.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/modpathol.3800689</ArticleId>
            <ArticleId IdType="pubmed">16980948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zen Y, Harada K, Sasaki M, et al.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–1203. doi: 10.1097/01.pas.0000136449.37936.6c.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.pas.0000136449.37936.6c</ArticleId>
            <ArticleId IdType="pubmed">15316319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deshpande V, Zen Y, Chan JK, et al.  Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–1192. doi: 10.1038/modpathol.2012.72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/modpathol.2012.72</ArticleId>
            <ArticleId IdType="pubmed">22596100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Negrelli R, Boninsegna E, Avesani G, et al.  Type 1 and type 2 autoimmune pancreatitis: distinctive clinical and pathological features, but are there any differences at magnetic resonance? Experience from a referral center. Pancreas. 2018;47:1115–1122. doi: 10.1097/MPA.0000000000001142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPA.0000000000001142</ArticleId>
            <ArticleId IdType="pubmed">30141780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manfredi R, Frulloni L, Mantovani W, Bonatti M, Graziani R, Pozzi Mucelli R. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology. 2011;260:428–436. doi: 10.1148/radiol.11101729.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiol.11101729</ArticleId>
            <ArticleId IdType="pubmed">21613442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Negrelli R, Manfredi R, Pedrinolla B, et al.  Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings. Eur Radiol. 2015;25:359–367. doi: 10.1007/s00330-014-3371-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-014-3371-y</ArticleId>
            <ArticleId IdType="pubmed">25106489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi N, Fletcher JG, Fidler JL, Hough DM, Kawashima A, Chari ST. Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol. 2008;190:280–286. doi: 10.2214/AJR.07.2309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.07.2309</ArticleId>
            <ArticleId IdType="pubmed">18212210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi N, Fletcher JG, Hough DM, et al.  Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT. AJR Am J Roentgenol. 2009;193:479–484. doi: 10.2214/AJR.08.1883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.08.1883</ArticleId>
            <ArticleId IdType="pubmed">19620446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park SH, Kim D, Ye BD, et al.  The characteristics of ulcerative colitis associated with autoimmune pancreatitis. J Clin Gastroenterol. 2013;47:520–525. doi: 10.1097/MCG.0b013e31827fd4a2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MCG.0b013e31827fd4a2</ArticleId>
            <ArticleId IdType="pubmed">23426453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sah RP, Chari ST, Pannala R, et al.  Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140–148. doi: 10.1053/j.gastro.2010.03.054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2010.03.054</ArticleId>
            <ArticleId IdType="pubmed">20353791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Pretis N, Vieceli F, Brandolese A, Brozzi L, Amodio A, Frulloni L. Autoimmune pancreatitis not otherwise specified (NOS): clinical features and outcomes of the forgotten type. Hepatobiliary Pancreat Dis Int. 2019;18:576–579. doi: 10.1016/j.hbpd.2019.05.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.hbpd.2019.05.010</ArticleId>
            <ArticleId IdType="pubmed">31248720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sokollik C, McLin VA, Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. Juvenile autoimmune hepatitis: a comprehensive review. J Autoimmun. 2018;95:69–76. doi: 10.1016/j.jaut.2018.10.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaut.2018.10.007</ArticleId>
            <ArticleId IdType="pubmed">30344030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terziroli Beretta-Piccoli B, Vergani D, Mieli-Vergani G. Autoimmune sclerosing cholangitis: Evidence and open questions. J Autoimmun. 2018;95:15–25. doi: 10.1016/j.jaut.2018.10.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaut.2018.10.008</ArticleId>
            <ArticleId IdType="pubmed">30366655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alswat K, Al-Harthy N, Mazrani W, Alshumrani G, Jhaveri K, Hirschfield GM. The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice. Am J Gastroenterol. 2012;107:56–63. doi: 10.1038/ajg.2011.375.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2011.375</ArticleId>
            <ArticleId IdType="pubmed">22068666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mendes FD, Jorgensen R, Keach J, et al.  Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101:2070–2075. doi: 10.1111/j.1572-0241.2006.00772.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1572-0241.2006.00772.x</ArticleId>
            <ArticleId IdType="pubmed">16879434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartholomew SV, Zigman A, Sheppard B. Lymphoplasmacytic sclerosing pancreatitis presenting as a pancreatic head mass in a child: case report and management recommendations. J Pediatr Surg. 2006;41:e23–e25. doi: 10.1016/j.jpedsurg.2005.12.052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpedsurg.2005.12.052</ArticleId>
            <ArticleId IdType="pubmed">16677871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blejter J, Weller S, Pace R, Cusumano H, Giambini D. Autoimmune pancreatitis: an adolescent case and review of literature. J Pediatr Surg. 2008;43:1368–1372. doi: 10.1016/j.jpedsurg.2008.02.064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpedsurg.2008.02.064</ArticleId>
            <ArticleId IdType="pubmed">18639699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedlander J, Quiros JA, Morgan T, et al.  Diagnosis of autoimmune pancreatitis vs neoplasms in children with pancreatic mass and biliary obstruction. Clin Gastroenterol Hepatol. 2012;10:1051–1055. doi: 10.1016/j.cgh.2012.06.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cgh.2012.06.014</ArticleId>
            <ArticleId IdType="pubmed">22732272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gargouri L, Ponsot P, Viala J, et al.  Recurrent autoimmune pancreatitis in a 10-year-old boy. J Pediatr Gastroenterol Nutr. 2009;48:374–377. doi: 10.1097/MPG.0b013e3181826dca.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPG.0b013e3181826dca</ArticleId>
            <ArticleId IdType="pubmed">19274796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Refaat R, Harth M, Proschek P, Lindemayr S, Vogl TJ. Autoimmune pancreatitis in an 11-year-old boy. Pediatr Radiol. 2009;39:389–392. doi: 10.1007/s00247-008-1132-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00247-008-1132-2</ArticleId>
            <ArticleId IdType="pubmed">19190899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheers I, Palermo JJ, Freedman S, et al.  Autoimmune pancreatitis in children: characteristic features, diagnosis, and management. Am J Gastroenterol. 2017;112:1604–1611. doi: 10.1038/ajg.2017.85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2017.85</ArticleId>
            <ArticleId IdType="pmc">PMC5908471</ArticleId>
            <ArticleId IdType="pubmed">28374818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart PA, Chari ST. Editorial: autoimmune pancreatitis in children: is this a new subtype of disease or early-onset idiopathic duct-centric chronic pancreatitis? Am J Gastroenterol. 2017;112:1613–1614. doi: 10.1038/ajg.2017.236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2017.236</ArticleId>
            <ArticleId IdType="pubmed">28978971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grammatikopoulos T, Zen Y, Portmann B, et al.  Steroid-responsive autoimmune sclerosing cholangitis with liver granulocytic epithelial lesions. J Pediatr Gastroenterol Nutr. 2013;56:e3–e4. doi: 10.1097/MPG.0b013e3182487173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPG.0b013e3182487173</ArticleId>
            <ArticleId IdType="pubmed">22241508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zen Y, Grammatikopoulos T, Heneghan MA, Vergani D, Mieli-Vergani G, Portmann BC. Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy. Am J Surg Pathol. 2012;36:1555–1561. doi: 10.1097/PAS.0b013e31825faae0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PAS.0b013e31825faae0</ArticleId>
            <ArticleId IdType="pubmed">22982898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Detlefsen S, Olesen SS. Sialadenitis in a patient with ulcerative colitis and autoimmune pancreatitis type 2. Pathol Res Pract. 2020;216:153072.  doi: 10.1016/j.prp.2020.153072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.prp.2020.153072</ArticleId>
            <ArticleId IdType="pubmed">32825945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ollo D, Terraz S, Arnoux G, Puppa G, Frossard JL, Bichard P. Biliary involvement in type 2 autoimmune pancreatitis. Case Rep Gastroenterol. 2019;13:200–206. doi: 10.1159/000499422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000499422</ArticleId>
            <ArticleId IdType="pmc">PMC6514518</ArticleId>
            <ArticleId IdType="pubmed">31123447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Detlefsen S, Zamboni G, Frulloni L, et al.  Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: a study of 114 surgically treated European patients. Pancreatology. 2012;12:276–283. doi: 10.1016/j.pan.2012.03.055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pan.2012.03.055</ArticleId>
            <ArticleId IdType="pubmed">22687385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maire F, Le Baleur Y, Rebours V, et al.  Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol. 2011;106:151–156. doi: 10.1038/ajg.2010.314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2010.314</ArticleId>
            <ArticleId IdType="pubmed">20736934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ku Y, Hong SM, Fujikura K, et al.  IL-8 expression in granulocytic epithelial lesions of idiopathic duct-centric pancreatitis (type 2 autoimmune pancreatitis) Am J Surg Pathol. 2017;41:1129–1138. doi: 10.1097/PAS.0000000000000891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PAS.0000000000000891</ArticleId>
            <ArticleId IdType="pubmed">28614208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y, Shi M, Yu GZ, et al.  Interleukin-8, a promising predictor for prognosis of pancreatic cancer. World J Gastroenterol. 2012;18:1123–1129. doi: 10.3748/wjg.v18.i10.1123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v18.i10.1123</ArticleId>
            <ArticleId IdType="pmc">PMC3296988</ArticleId>
            <ArticleId IdType="pubmed">22416189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta R, Neyaz A, Chougule A, et al.  Autoimmune pancreatitis type 2: diagnostic utility of PD-L1 immunohistochemistry. Am J Surg Pathol. 2019;43:898–906. doi: 10.1097/PAS.0000000000001282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PAS.0000000000001282</ArticleId>
            <ArticleId IdType="pubmed">31135488</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
